News
Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...
Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...
1d
theAsianparent on MSNSMART and KKH Develop First-of-Its-Kind Device (BLIPI) to Profile Newborns’ Immune FunctionIn a revolutionary leap for neonatal healthcare, researchers from the Critical Analytics for Manufacturing ...
"Given the pace of AI innovation, we are confident that this is not a distant dream, but a reality that will unfold in the ...
The Enigma AI platform was successfully piloted at SingHealth institutions. Read more at straitstimes.com. Read more at ...
Bloomberg on MSN7d
MiRXES Says China Will Be An Important MarketMiRXES Co-Founder & CEO Lihan Zhou says the Chinese market is key, as it gives his company the scale to bring down cost. The Singapore-based biotechnology startup made its Hong Kong initial public ...
Find out how efficient Asia’s healthcare system is with Prof Himanshu Rai at the Indian Institute of Management Indore ...
At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore in the next 12 to 18 months, four sources said, as Chinese firms look to ...
Canadian biotechnology company Quantum Biopharma has bought an additional $1 million worth of Bitcoin and other ...
China has long pushed for closer economic ties with the region, especially as it feuds with Washington on multiple fronts. Chinese firms see Southeast Asia as a fast-growing market that is home to a ...
At least five companies from mainland China or Hong Kong are planning IPOs, dual listings, or share placements in Singapore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results